tiprankstipranks
Trending News
More News >
Arvinas Holding Company (ARVN)
NASDAQ:ARVN
US Market

Arvinas Holding Company (ARVN) Stock Forecast & Price Target

Compare
995 Followers
See the Price Targets and Ratings of:

ARVN Analyst Ratings

Moderate Buy
19Ratings
Moderate Buy
10 Buy
9 Hold
0 Sell
Based on 19 analysts giving stock ratings to
Arvinas
Holding Company
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ARVN Stock 12 Month Forecast

Average Price Target

$14.43
▲(96.86%Upside)
Based on 19 Wall Street analysts offering 12 month price targets for Arvinas Holding Company in the last 3 months. The average price target is $14.43 with a high forecast of $24.00 and a low forecast of $8.00. The average price target represents a 96.86% change from the last price of $7.33.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","13":"$13","20":"$20","27":"$27","34":"$34"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$24.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$14.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$8.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,13,20,27,34],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.33,8.612307692307692,9.894615384615385,11.176923076923078,12.45923076923077,13.741538461538461,15.023846153846154,16.306153846153848,17.588461538461537,18.870769230769234,20.153076923076924,21.435384615384613,22.71769230769231,{"y":24,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.33,7.876153846153846,8.422307692307692,8.968461538461538,9.514615384615384,10.06076923076923,10.606923076923078,11.153076923076924,11.69923076923077,12.245384615384616,12.791538461538462,13.337692307692308,13.883846153846154,{"y":14.43,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.33,7.381538461538462,7.433076923076923,7.484615384615385,7.536153846153846,7.587692307692308,7.639230769230769,7.690769230769231,7.742307692307692,7.793846153846154,7.845384615384615,7.896923076923077,7.9484615384615385,{"y":8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":33.14,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.98,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.78,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.16,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.88,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.9,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.72,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.17,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.61,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.7,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.03,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.23,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.33,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$24.00Average Price Target$14.43Lowest Price Target$8.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ARVN
TipRanks AITipRanks
Not Ranked
TipRanks
$7
Hold
-4.50%
Downside
Reiterated
06/02/25
Arvinas's overall stock score reflects strong revenue growth and positive strategic developments from recent earnings calls, but is weighed down by ongoing profitability challenges and mixed technical indicators. The company's negative valuation metrics further contribute to a cautious outlook.
H.C. Wainwright Analyst forecast on ARVN
Andrew FeinH.C. Wainwright
H.C. Wainwright
$24
Buy
227.42%
Upside
Reiterated
06/02/25
Promising Phase 3 Results and Strategic Partnerships Drive Buy Rating for Arvinas
Bank of America Securities Analyst forecast on ARVN
Tazeen AhmadBank of America Securities
Bank of America Securities
Buy
Reiterated
06/02/25
Arvinas Holding Company (ARVN) Receives a Buy from Bank of America Securities
Truist Financial Analyst forecast on ARVN
Srikripa DevarakondaTruist Financial
Truist Financial
Hold
Reiterated
06/02/25
Arvinas Holding Company (ARVN) Receives a Hold from Truist Financial
TD Cowen
Hold
Reiterated
06/02/25
TD Cowen Remains a Hold on Arvinas Holding Company (ARVN)
Barclays Analyst forecast on ARVN
Peter LawsonBarclays
Barclays
$16
Buy
118.28%
Upside
Reiterated
06/02/25
Arvinas Holding Company (ARVN) Gets a Buy from Barclays
Oppenheimer Analyst forecast on ARVN
Matthew BieglerOppenheimer
Oppenheimer
Hold
Reiterated
06/02/25
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (NASDAQ: ARVN) and Bristol-Myers Squibb (NYSE: BMY)
Piper Sandler Analyst forecast on ARVN
Edward TenthoffPiper Sandler
Piper Sandler
$14
Buy
91.00%
Upside
Reiterated
06/02/25
Piper Sandler Sticks to Its Buy Rating for Arvinas Holding Company (ARVN)
Wells Fargo Analyst forecast on ARVN
Derek ArchilaWells Fargo
Wells Fargo
$19
Buy
159.21%
Upside
Reiterated
06/01/25
Buy Rating Justified by Arvinas Holding's Promising Early-Stage Pipeline Despite Modest Trial Results
Leerink Partners Analyst forecast on ARVN
Andrew BerensLeerink Partners
Leerink Partners
$12$9
Hold
22.78%
Upside
Downgraded
06/01/25
Hold Rating on Arvinas Holding Amid Uncertainties in Vepdegestrant's Market Potential
UBS
$74$21
Buy
186.49%
Upside
Reiterated
05/15/25
Arvinas price target lowered to $21 from $74 at UBSArvinas price target lowered to $21 from $74 at UBS
Morgan Stanley Analyst forecast on ARVN
Terence FlynnMorgan Stanley
Morgan Stanley
$12$11
Hold
50.07%
Upside
Reiterated
05/09/25
Arvinas Inc. (ARVN) PT Lowered to $11 at Morgan StanleyMorgan Stanley analyst Terence Flynn lowered the price target on Arvinas Inc. (NASDAQ: ARVN) to $11.00 (from $12.00) while maintaining a Equalweight rating.
Citi
$10$9.5
Hold
29.60%
Upside
Reiterated
05/04/25
Arvinas price target lowered to $9.50 from $10 at CitiArvinas price target lowered to $9.50 from $10 at Citi
Guggenheim Analyst forecast on ARVN
Michael SchmidtGuggenheim
Guggenheim
$32$16
Buy
118.28%
Upside
Reiterated
05/02/25
Analysts Offer Insights on Healthcare Companies: Stryker (NYSE: SYK), Arvinas Holding Company (NASDAQ: ARVN) and Ardelyx (NASDAQ: ARDX)
BMO Capital Analyst forecast on ARVN
Evan SeigermanBMO Capital
BMO Capital
$20$10
Buy
36.43%
Upside
Reiterated
05/02/25
Arvinas price target lowered to $10 from $20 at BMO CapitalArvinas price target lowered to $10 from $20 at BMO Capital
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ARVN
TipRanks AITipRanks
Not Ranked
TipRanks
$7
Hold
-4.50%
Downside
Reiterated
06/02/25
Arvinas's overall stock score reflects strong revenue growth and positive strategic developments from recent earnings calls, but is weighed down by ongoing profitability challenges and mixed technical indicators. The company's negative valuation metrics further contribute to a cautious outlook.
H.C. Wainwright Analyst forecast on ARVN
Andrew FeinH.C. Wainwright
H.C. Wainwright
$24
Buy
227.42%
Upside
Reiterated
06/02/25
Promising Phase 3 Results and Strategic Partnerships Drive Buy Rating for Arvinas
Bank of America Securities Analyst forecast on ARVN
Tazeen AhmadBank of America Securities
Bank of America Securities
Buy
Reiterated
06/02/25
Arvinas Holding Company (ARVN) Receives a Buy from Bank of America Securities
Truist Financial Analyst forecast on ARVN
Srikripa DevarakondaTruist Financial
Truist Financial
Hold
Reiterated
06/02/25
Arvinas Holding Company (ARVN) Receives a Hold from Truist Financial
TD Cowen
Hold
Reiterated
06/02/25
TD Cowen Remains a Hold on Arvinas Holding Company (ARVN)
Barclays Analyst forecast on ARVN
Peter LawsonBarclays
Barclays
$16
Buy
118.28%
Upside
Reiterated
06/02/25
Arvinas Holding Company (ARVN) Gets a Buy from Barclays
Oppenheimer Analyst forecast on ARVN
Matthew BieglerOppenheimer
Oppenheimer
Hold
Reiterated
06/02/25
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (NASDAQ: ARVN) and Bristol-Myers Squibb (NYSE: BMY)
Piper Sandler Analyst forecast on ARVN
Edward TenthoffPiper Sandler
Piper Sandler
$14
Buy
91.00%
Upside
Reiterated
06/02/25
Piper Sandler Sticks to Its Buy Rating for Arvinas Holding Company (ARVN)
Wells Fargo Analyst forecast on ARVN
Derek ArchilaWells Fargo
Wells Fargo
$19
Buy
159.21%
Upside
Reiterated
06/01/25
Buy Rating Justified by Arvinas Holding's Promising Early-Stage Pipeline Despite Modest Trial Results
Leerink Partners Analyst forecast on ARVN
Andrew BerensLeerink Partners
Leerink Partners
$12$9
Hold
22.78%
Upside
Downgraded
06/01/25
Hold Rating on Arvinas Holding Amid Uncertainties in Vepdegestrant's Market Potential
UBS
$74$21
Buy
186.49%
Upside
Reiterated
05/15/25
Arvinas price target lowered to $21 from $74 at UBSArvinas price target lowered to $21 from $74 at UBS
Morgan Stanley Analyst forecast on ARVN
Terence FlynnMorgan Stanley
Morgan Stanley
$12$11
Hold
50.07%
Upside
Reiterated
05/09/25
Arvinas Inc. (ARVN) PT Lowered to $11 at Morgan StanleyMorgan Stanley analyst Terence Flynn lowered the price target on Arvinas Inc. (NASDAQ: ARVN) to $11.00 (from $12.00) while maintaining a Equalweight rating.
Citi
$10$9.5
Hold
29.60%
Upside
Reiterated
05/04/25
Arvinas price target lowered to $9.50 from $10 at CitiArvinas price target lowered to $9.50 from $10 at Citi
Guggenheim Analyst forecast on ARVN
Michael SchmidtGuggenheim
Guggenheim
$32$16
Buy
118.28%
Upside
Reiterated
05/02/25
Analysts Offer Insights on Healthcare Companies: Stryker (NYSE: SYK), Arvinas Holding Company (NASDAQ: ARVN) and Ardelyx (NASDAQ: ARDX)
BMO Capital Analyst forecast on ARVN
Evan SeigermanBMO Capital
BMO Capital
$20$10
Buy
36.43%
Upside
Reiterated
05/02/25
Arvinas price target lowered to $10 from $20 at BMO CapitalArvinas price target lowered to $10 from $20 at BMO Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Arvinas Holding Company

1 Month
xxx
Success Rate
7/14 ratings generated profit
50%
Average Return
+2.55%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +2.55% per trade.
3 Months
xxx
Success Rate
6/14 ratings generated profit
43%
Average Return
+0.04%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +0.04% per trade.
1 Year
Tazeen AhmadBank of America Securities
Success Rate
6/14 ratings generated profit
43%
Average Return
-8.56%
reiterated a buy rating 2 days ago
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -8.56% per trade.
2 Years
xxx
Success Rate
3/11 ratings generated profit
27%
Average Return
-17.34%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 27.27% of your transactions generating a profit, with an average return of -17.34% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARVN Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
26
26
29
22
19
Buy
3
7
8
8
4
Hold
0
6
8
13
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
29
39
45
43
34
In the current month, ARVN has received 23 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. ARVN average Analyst price target in the past 3 months is 14.43.
Each month's total comprises the sum of three months' worth of ratings.

ARVN Financial Forecast

ARVN Earnings Forecast

Next quarter’s earnings estimate for ARVN is -$0.94 with a range of -$1.45 to $0.26. The previous quarter’s EPS was $1.14. ARVN beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.55% of the time in the same period. In the last calendar year ARVN has Outperformed its overall industry.
Next quarter’s earnings estimate for ARVN is -$0.94 with a range of -$1.45 to $0.26. The previous quarter’s EPS was $1.14. ARVN beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.55% of the time in the same period. In the last calendar year ARVN has Outperformed its overall industry.

ARVN Sales Forecast

Next quarter’s sales forecast for ARVN is $34.56M with a range of $0.00 to $106.60M. The previous quarter’s sales results were $188.80M. ARVN beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 44.10% of the time in the same period. In the last calendar year ARVN has Outperformed its overall industry.
Next quarter’s sales forecast for ARVN is $34.56M with a range of $0.00 to $106.60M. The previous quarter’s sales results were $188.80M. ARVN beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 44.10% of the time in the same period. In the last calendar year ARVN has Outperformed its overall industry.

ARVN Stock Forecast FAQ

What is ARVN’s average 12-month price target, according to analysts?
Based on analyst ratings, Arvinas Holding Company’s 12-month average price target is 14.43.
    What is ARVN’s upside potential, based on the analysts’ average price target?
    Arvinas Holding Company has 96.86% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ARVN a Buy, Sell or Hold?
          Arvinas Holding Company has a consensus rating of Moderate Buy which is based on 10 buy ratings, 9 hold ratings and 0 sell ratings.
            What is Arvinas Holding Company’s price target?
            The average price target for Arvinas Holding Company is 14.43. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $24.00 ,the lowest forecast is $8.00. The average price target represents 96.86% Increase from the current price of $7.33.
              What do analysts say about Arvinas Holding Company?
              Arvinas Holding Company’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of ARVN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis